Patent Assignment
Reel/Frame 029227/0929
Change of Name
Recorded: 2012-11-02
Pages: 12
Assignor
HARBOR BIOSCIENCES, INC.
Executed: 2012-02-01
Assignee
HARBOR DIVERSIFIED, INC.
9191 TOWNE CENTRE DRIVE, SUITE 409, SAN DIEGO, CALIFORNIA, 92122
Covered Properties
(164)
Therapeutic Treatment Methods
PCT:
PCT/US2003/027186 ↗
Antiandrogens with Marginal Agonist Activity and Methods of Use
PCT:
PCT/US2004/009739 ↗
Steroid Analogs and Characterization and Treatment Methods
PCT:
PCT/US2005/035020 ↗
Treatment Screening Methods
PCT:
PCT/US2005/035786 ↗
Drugs and Uses
PCT:
PCT/US2007/067235 ↗
Stabilized Therapeutic Compositions and Formulations
PCT:
PCT/US2008/073933 ↗
Pharmaceutical Solid State Forms
PCT:
PCT/US2009/033280 ↗
Solid State Forms of a Pharmaceutical
PCT:
PCT/US2009/039567 ↗
Methods for Preparing 17-Alkynyl-7-Hydroxy Steroids and Related Compounds
PCT:
PCT/US2009/046477 ↗
Patient Populations and Treatment Methods
PCT:
PCT/US2009/058260 ↗
Anticancer Compounds and Screening Method
PCT:
PCT/US2010/058449 ↗
Methods and Compounds for Preparing 3ALPHA-Oxygen Substituted Steroids
PCT:
PCT/US2011/065298 ↗
Steroid Tetrol Solid State Forms
PCT:
PCT/US2011/065482 ↗
Steroid Tetrol Solid State Forms-2
PCT:
PCT/US2011/065552 ↗
Pharmaceutical Formulation and Therapeutic Method for Treatment of Viral Infections
Application:
07/090,637 →
Agents for the Arrest and Theraoy of Retroviral Infections
Patent:
4,956,355 →
Application:
07/182,480 →
Administering Particular Compounds Against Various Parasites, Mycoplasmas, Other Indications and Other Infections
Patent:
5,292,725 →
Application:
07/719,017 →
Method of Treating Viral and Retroviral Infections Including Hiv by Administration Off N6-((Delta)2-Isopentenyl) Adenosine or an Analogue Thereof
Patent:
5,681,831 →
Application:
08/251,659 →
DELTA5-Androstenes Useful for Promoting Weight Maintenance or Weight Loss and Treatment Process
Patent:
5,424,463 →
Application:
08/327,843 →
5-Androstene-3B,17XDIOL as an Inhibitor of Tumor Growth
Pharmaceutical Compositions and Treatment Methods
Application:
09/414,905 →
Process for Effecting Allylic Oxidation Using Dicarboxylic Acid Imides and Chromium Reagents
Patent:
6,384,251 →
Application:
09/423,467 →
Use of 17-Ketosteroid Compounds and Derivatives, Metabolites and Precursors Thereof in the Treatment of Malaria and the Treatment of African and American Trypansomias
Application:
09/449,004 →
Use of 17-Ketosteroid Compounds and Derivatives, Metabolites and Precursors Thereof in Treatment of Toxoplasmosis and in the Treatment of Cryptosporidiosis
Application:
09/449,042 →
Use of 17-Ketosteroid Compounds and Derivatives, Metabolites and Precursors Thereof in the Treament of Hepatitis C Virus and Other Togaviruses
Application:
09/449,184 →
Cytokine combination therapy
Application:
09/461,026 →
Pharmaceutical Compositions and Treatment Methods
Patent:
6,667,299 →
Application:
09/535,675 →
Treatment methods using formulations comprising micronized and non-micronized compounds
Application:
09/586,672 →
Infection treatment compositions and methods
Application:
09/586,673 →
Therapeutic treatment of androgen receptor driven conditions
Application:
09/675,323 →
Therapeutic treatments for blood cell deficiencies
Application:
09/675,470 →
Method of Treatment of Prostate Cancer
Immune modulation method using steroid compounds
Application:
09/820,483 →
Publication:
US 2003/0060425
Blood cell deficiency treatment method
Application:
10/087,929 →
Publication:
US 2003/0083231
Pharmaceutical Compositions and Treatment Methods
Pharmaceutical compositions and treatment methods
Application:
10/329,065 →
Publication:
US 2004/0116359
Compounds useful for treating hypertriglyceridemia
Application:
10/408,466 →
Publication:
US 2004/0019026
7-Hydroxy-16alpha-fluoro-5-androsten-17-ones and 7-hydroxy-16alpha-fluoro-5-androstan-17-ones and derivatives thereof
Application:
10/427,280 →
Publication:
US 2004/0034003
Therapeutic treatment methods
Application:
10/526,321 →
Pharmaceutical compositions and treatment methods
Application:
10/602,330 →
Publication:
US 2004/0220114
Pharmaceutical compositions and treatment methods - 4
Application:
10/607,035 →
Publication:
US 2004/0097406
Tetrol Steroids and Esters
Therapeutic treatment methods
Application:
10/651,515 →
Publication:
US 2004/0138187
Therapeutic treatment methods 2
Application:
10/728,400 →
Publication:
US 2005/0101581
Pharmaceutical compositions and treatment methods-6
Application:
10/741,929 →
Publication:
US 2004/0220161
Antiandrogens with marginal agonist activity and methods of use
Application:
10/814,503 →
Publication:
US 2004/0242618
Pharmaceutical compositions and treatment methods-7
Application:
10/876,957 →
Publication:
US 2005/0282732
Pharmaceutical treatments and compositions
Application:
10/877,911 →
Publication:
US 2007/0129282
Pharmaceutical compositions and treatment methods - 8
Application:
10/890,490 →
Publication:
US 2005/0159366
Esters of Tetrahydroxy Steroids
Application:
10/949,694 →
Publication:
US 2005/0256095
Neurological disorder treatment methods
Application:
10/949,782 →
Publication:
US 2005/0075321
Compositions and treatment methods
Application:
11/234,675 →
Publication:
US 2006/0079492
Steroid analogs and characterization and treatment methods
Application:
11/241,670 →
Publication:
US 2007/0014719
Treatment screening methods
Application:
11/241,678 →
Publication:
US 2006/0073099
Treatment screening methods
Application:
11/242,547 →
Publication:
US 2006/0088473
Drug product and process for making
Application:
11/355,561 →
Publication:
US 2007/0053832
Stem Cell Expansion and Uses
Surrogate markers
Application:
11/389,319 →
Publication:
US 2007/0077203
Cystic Fibrosis Treatment Methods
Pharmaceutical compositions
Application:
11/549,606 →
Publication:
US 2007/0203107
Disease treatment methods
Application:
11/549,615 →
Publication:
US 2008/0085873
Asthma Treatment Methods
Application:
11/549,825 →
Publication:
US 2007/0265236
Sepsis Treatment Methods
Pharmaceutical Compositions - 2
Application:
11/551,195 →
Publication:
US 2009/0215737
Pharmaceutical Compositions
Application:
11/551,202 →
Publication:
US 2008/0045490
Pharmaceutical Compositions 3
Formulations and Treatment Methods
Application:
11/564,026 →
Publication:
US 2007/0275936
Therapeutic Treatment Methods
Therapeutic Treatment Methods
Metabolic Disease Treatments
Application:
11/696,637 →
Publication:
US 2008/0015174
Pharmaceutical Compositions
Formulations
Prostate and Breast Cancer Treatment
Patent:
7,696,189 →
Application:
11/835,394 →
Breast and Prostate Cancer Treatment Method
Prostate Cancer Treatment
Steroids Having 1,8-Unsaturation and Formulations Comprising Same
Prostate Cancer Treatment
Drug Screen and Treatment Method
Application:
11/941,934 →
Publication:
US 2008/0221074
Drug Identification and Treatment Method
Drug Screening and Treatment Methods
Drug Identification and Treatment Method
Application:
11/942,689 →
Publication:
US 2008/0153792
Stabilized Therapeutic Compositions and Formulations
Application:
12/196,271 →
Publication:
US 2009/0258850
Steroid Tetrol Solid State Forms
Pharmaceutical Solid State Forms
Diene Compounds and Formulations
Diene and Triene Compounds and Formulations
Solid State Forms of a Pharmaceutical
Methods for Preparing 17-Alkynyl-7-Hydroxy Steroids and Related Compounds
Patient populations and treatment methods
Application:
12/566,565 →
Publication:
US 2010/0075937
Compounds and Compositions
15-Oxa-Steroid Compunds
Pharmaceutical Compositions-4
Patient populations and treatment methods
Application:
12/731,692 →
Publication:
US 2010/0222315
Patient populations and treatment methods
Application:
12/732,164 →
Publication:
US 2010/0227841
Cancer Treatment Methods
Unsaturated Steroid Compounds
Application:
12/905,778 →
Publication:
US 2011/0028711
Anticancer Compounds and Screening Method
Application:
12/957,273 →
Publication:
US 2011/0129423
Steroid Compounds and Formulations
Drug Product and Process for Making
Application:
12/968,028 →
Publication:
US 2011/0085984
Unsaturated Steroid Compounds
Steroids Having 7-Oxgen and 17-Heteroaryl Substitution
15-Thia Steroid Compounds and Compositions
Application:
13/107,573 →
Publication:
US 2011/0218162
11-Aza, 11-Thia and 11-Oxa Sterol Compounds and Compositions
Screening and Treatment Method
Application:
13/252,846 →
Publication:
US 2012/0029260
Steroid Compounds and Treatment Methods
Methods and Compounds for Preparing 3ALPHA-Oxygen Substituted Steroids
Application:
13/327,701 →
Publication:
US 2012/0214987
Steroid Tetrol Solid State Forms
Application:
13/328,374 →
Publication:
US 2012/0220560
Steroid Tetrol Solid State Forms - 2
Application:
13/328,760 →
Publication:
US 2012/0252774
Use of 17-Ketosteroid Compounds and Derivatives, Metabolites and Precursors Thereof in Treatment of Malaria, Treatment of African Trypanosomiasis and Treatment of American Trypanosomiasis as Well as Other Indications and Infections
Application:
60/109,923 →
Use of 17-Ketosteroid Compounds and Derivatives, Metabolites and Precursors Thereof in Treatment of Hepatitis C and Other Togaviruses
Application:
60/109,924 →
Use of 17-Ketosteroid Compounds and Derivatives, Metabolites and Precursors Thereof in Treatment of Toxoplasmosis and/or in Treatment of Cryptosporidiosis
Application:
60/110,127 →
Cytokine Combination Therapy
Application:
60/112,206 →
Pharmaceutical Compositions and Treatment Methods
Application:
60/124,087 →
Pharmaceutical Compositions and Treatment Methods
Application:
60/126,056 →
Methods of Treating and/or Reducing the Likelihood of Viral Infection, Bacterial Infection, Toxoplasmosis, Cryptosporidiosis, Malaria, Aftican Trypanosomoiasis, American Trypanosomiasis, Bone Marrow Rejection, Organ Rejection, Compromised Immune System in the El
Application:
60/137,745 →
Compound Screening Method
Application:
60/140,028 →
Methods of Treating and/or Reducing the Likelihood of Viral Infection Bacterial Infection, Parasitic Infection, Bone Marrow Rejection, Organ Rejection, Compromised Immune System in the Elderly and Other Conditions, and Formulations for Use in Such Methods
Application:
60/142,386 →
Methods of Treating and/or Reducing the Likelihood of Viral Infection, Bacterial Infection, Parasite Infection, Fungal Infection, and Compositions and Formulations for Use in Such Methods
Application:
60/145,823 →
Pharmaceutical Compositions and Treatment Methods
Application:
60/157,275 →
Pharmaceutical Compositions and Treatment Methods
Application:
60/157,347 →
Immune Response Modulation Methods
Application:
60/164,048 →
Pharmaceutical Compositions and Treatment Methods
Application:
60/166,116 →
Pharmaceutical compositions and treatment methods
Application:
60/190,140 →
Use of dhea analogs for treating hypertriglyceridemia
Application:
60/238,659 →
Treatment methods for immune disregulation conditions including immune senescence
Application:
60/257,071 →
Ergosteroids IV: synthesis and biological activity of steroid glucuronosides, ethers and alkylcarbonates
Application:
60/272,624 →
Immune modulation method using steroid compounds
Application:
60/323,016 →
Immune modulation method using steroid compounds
Application:
60/338,015 →
Immune modulation method using steroid compounds
Application:
60/340,054 →
Immune modulation method using steroid compounds
Application:
60/343,523 →
Immune dysregulation treatment method
Application:
60/407,146 →
Screening methods for immune modulators I
Application:
60/408,332 →
Antiandrogens with marginal agonist activity and methods of use therefore
Application:
60/459,450 →
Steroid analogs, assay methods and treatment methods
Application:
60/614,869 →
Treatment methods and surrogate markers
Application:
60/615,307 →
Steroid sparing method
Application:
60/628,252 →
Inflammation treatment method
Application:
60/793,792 →
Inflammation Treatment Method 2
Application:
60/825,564 →
Modulation of Inflammation
Application:
60/825,569 →
Metabolic Disease Treatments
Application:
60/829,848 →
Inflammation treatment method
Application:
60/843,112 →
T Cell Modulation Methods
Application:
60/866,395 →
Biodynamic Drugs and Uses
Application:
60/866,700 →
Drugs and Uses
Application:
60/868,042 →
Metabolic Disease Treatments
Application:
60/885,003 →
T Cell Modulation Methods
Application:
60/888,058 →
Efficacy stabilized therapeutic compositions
Application:
60/965,730 →
Crystalline and Amorphous Pharmaceuticals
Application:
61/026,472 →
Crystalline and Amorphous Pharmaceuticals
Application:
61/042,240 →
Methods for Preparing 17-Alkynyl-7-Hydroxy Steroids and Related Compounds
Application:
61/059,658 →
Crystalline and Amorphous Pharmaceuticals-2
Application:
61/093,694 →
Metabolic disease surrogate biomarkers and uses
Application:
61/099,880 →
Metabolic disease surrogate biomarkers and uses - 2
Application:
61/100,246 →
Metabolic disease surrogate biomarkers and uses - 3
Application:
61/162,620 →
Patient subpopulations and treatment methods
Application:
61/184,283 →
Patient subpopulations and treatment methods
Application:
61/186,360 →
Anticancer compounds and screening method
Application:
61/265,294 →
Anticancer compounds and screening method
Application:
61/266,092 →
Anticancer compounds and screening method
Application:
61/266,291 →
Anticancer compounds and screening method - 2
Application:
61/266,416 →
Anticancer compounds and screening method - 3
Application:
61/266,483 →
Methods and Compounds for Preparing 3ALPHA-Oxygen Substituted Steroids
Application:
61/423,457 →
Steroid Tetrol Solid State Forms-2
Application:
61/424,156 →
Steroid Tetrol Solid State Forms
Application:
61/424,173 →
Related Assignments
(25)
Other recorded transfers of the patents in this record — the chain of ownership.
Security Agreement
Dec 4, 2009
From: HUMANETICS CORPORATION
To: HOPFENSPIRGER, LARRY
Reel/Frame 023594/0680 →
Change of Name
Mar 11, 2010
From: HOLLIS-EDEN PHARMACEUTICALS, INC.
To: HARBOR BIOSCIENCES, INC.
Reel/Frame 024066/0325 →
Assignment of Assignor's Interest
Aug 5, 2013
From: WHITE, STEVEN K.; JANSEN, ERIN E.
To: HARBOR THERAPEUTICS, INC.
Reel/Frame 030943/0937 →
Assignment of Assignor's Interest
Aug 5, 2013
From: WHITE, STEVEN K.; JANSEN, ERIN E.
To: HARBOR THERAPEUTICS, INC.
Reel/Frame 030943/0711 →
Release of Security Interest
Jul 10, 2014
From: HOPFENSPIRGER, LARRY
To: HUMANETICS CORPORATION
Reel/Frame 033293/0475 →
Release of Security Interest
Jul 10, 2014
From: HOPFENSPIRGER, LARRY
To: HUMANETICS CORPORATION
Reel/Frame 033300/0527 →
Assignment of Assignor's Interest
Aug 27, 2014
From: HUMANETICS CORPORATION
To: INTERHEALTH NUTRACEUTICALS INCORPORATED
Reel/Frame 033645/0212 →
Assignment of Assignor's Interest
Feb 25, 2015
From: RESERVA LLC
To: NEURMEDIX INC.
Reel/Frame 035026/0292 →
Assignment of Assignor's Interest
Feb 25, 2015
From: RESERVA LLC
To: NEURMEDIX, INC.
Reel/Frame 035030/0541 →
Security Interest
Apr 23, 2015
From: INTERHEALTH NUTRACEUTICALS INCORPORATED
To: MADISON CAPITAL FUNDING LLC, AS ADMINISTRATIVE AGENT
Reel/Frame 035486/0554 →
Assignment of Assignor's Interest
Jul 10, 2015
From: RESERVA, LLC
To: NEURMEDIX, INC.
Reel/Frame 036057/0613 →
Merger and Change of Name
Jul 10, 2015
From: HARBOR BIOSCIENCES, INC.; HARBOR DIVERSIFIED, INC.
To: HARBOR DIVERSIFIED, INC.
Reel/Frame 036057/0142 →
Assignment of Assignor's Interest
Jul 10, 2015
From: HARBOR DIVERSIFIED, INC.
To: HARBOR THERAPEUTICS, INC.
Reel/Frame 036057/0392 →
Assignment of Assignor's Interest
Jan 28, 2016
From: HARBOR DIVERSIFIED, INC .
To: RESERVA LLC
Reel/Frame 037627/0618 →
Assignment of Assignor's Interest
Jan 29, 2016
From: HARBOR THERAPEUTICS, INC.
To: RESERVA LLC
Reel/Frame 037642/0639 →
Merger and Change of Name
Jan 29, 2016
From: HARBOR BIOSCIENCES, INC.; HARBOR DIVERSIFIED, INC .
To: HARBOR DIVERSIFIED, INC .
Reel/Frame 037618/0033 →
Assignment of Assignor's Interest
Jan 29, 2016
From: HARBOR DIVERSIFIED, INC .
To: HARBOR THERAPEUTICS, INC.
Reel/Frame 037618/0495 →
Assignment of Assignor's Interest
Feb 2, 2016
From: HARBOR THERAPEUTICS, INC.
To: RESERVA LLC
Reel/Frame 037681/0395 →
Assignment of Assignor's Interest
Feb 2, 2016
From: WHITE, STEVEN K; GE, YU; HUANG, YUJIN
To: HOLLIS-EDEN PHARMACEUTICALS, INC.
Reel/Frame 037643/0879 →
Release and Reassignment of Intellectual Property Security Interests
Aug 23, 2016
From: UNICREDIT BANK AG, NEW YORK BRANCH AS SECURED PARTY IN POSSESSION OF THE ASSETS OF HILCO FINANCIAL LLC
To: HUMANETICS CORPORATION; ADVANTRX CORPORATION
Reel/Frame 039784/0922 →
Release of Security Interest in Patents
Sep 12, 2016
From: MADISON CAPITAL FUNDING LLC, AS ADMINISTRATIVE AGENT
To: INTERHEALTH NUTRACEUTICALS INCORPORATED
Reel/Frame 040068/0687 →
Assignment of Assignor's Interest
Aug 3, 2017
From: HARBOR THERAPEUTICS, INC.
To: RESERVA, LLC
Reel/Frame 043443/0242 →
Assignment of Assignor's Interest
Aug 8, 2021
From: NEURMEDIX, INC.,
To: NEURMEDIX, LLC
Reel/Frame 057115/0345 →
Assignment of Assignor's Interest
Aug 8, 2021
From: NEURMEDIX, LLC
To: NEURMEDIX, INC.
Reel/Frame 057115/0401 →
Assignment of Assignor's Interest
Aug 8, 2021
From: NEURMEDIX, INC.
To: BIOVIE INC.
Reel/Frame 057115/0470 →